# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA878411 | F | Minimum inhibitory concentration of compound in vitro against echovirus-11 | echovirus-11 | 1 | organism-based format | Scientific Literature | ||
2. | ALA675558 | F | Minimum inhibitory concentration of compound in vitro against echovirus-9 | echovirus-9 | 1 | organism-based format | Scientific Literature | ||
3. | ALA724655 | F | In vitro antiviral activity against mice infected intracerebrally with Poliovirus type-2 | Mus musculus | 12 | organism-based format | Scientific Literature | ||
4. | ALA739420 | F | Effect of compound on number of survivors per 30 mice at dose 125 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
5. | ALA739421 | F | Effect of compound on number of survivors per 30 mice at dose 250 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
6. | ALA739422 | F | Effect of compound on number of survivors per 30 mice at dose 31 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
7. | ALA739423 | F | Effect of compound on number of survivors per 30 mice at dose 63 mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
8. | ALA739424 | F | Effect of compound on number of survivors per 30 mice at nonmed mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
9. | ALA739425 | F | Effect of compound on number of survivors per 30 mice at placebo mg/kg | Mus musculus | 1 | organism-based format | Scientific Literature | ||
10. | ALA748496 | F | Effect of compound on Poliovirus induced paralysis and death in mice when administered orally with 31 mg/kg. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
11. | ALA748497 | F | Effect of compound on Poliovirus induced paralysis and death in mice when administered orally with dose 125 mg/kg. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
12. | ALA748498 | F | Effect of compound on Poliovirus induced paralysis and death in mice when administered orally with dose 250 mg/kg. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
13. | ALA748499 | F | Effect of compound on Poliovirus induced paralysis and death in mice when administered orally with dose 63 mg/kg. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
14. | ALA748500 | F | Effect of compound on Poliovirus induced paralysis and death in mice when administered orally with nonmed mg/kg. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
15. | ALA748501 | F | Effect of compound on Poliovirus induced paralysis and death in mice when administered orally with placebo mg/kg. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
16. | ALA767552 | F | In vitro anti-picornavirus activity against Poliovirus type-2. | Poliovirus 2 | 19 | organism-based format | Scientific Literature | ||
17. | ALA767554 | F | Minimum inhibitory concentration of compound in vitro against poliovirus-2 | poliovirus-2 | 1 | organism-based format | Scientific Literature | ||
18. | ALA767555 | F | Minimum inhibitory concentration of compound in vitro against poliovirus-3 | poliovirus-3 | 1 | organism-based format | Scientific Literature | ||
19. | ALA801300 | F | Effect on plaque production by Human Rhinovirus serotype 13 | Enterovirus | 1 | organism-based format | Scientific Literature | ||
20. | ALA801301 | F | Effect on plaque production by Human Rhinovirus serotype 14 | Enterovirus | 1 | organism-based format | Scientific Literature |